Benefit Strategies to Bend Healthcare Cost Curves

Artificial intelligence is moving into clinical care. AI helps patients navigate complex systems and inform clinical decisions, while telemedicine continues to broaden access. 

Pharmacy is becoming the dominant cost driver. Prescription drugs are projected to exceed half of total medical spend, propelled by gene therapies, GLP-1s, and a full approval pipeline. 

Provider consolidation is reshaping negotiations. Fewer larger health systems mean higher unit prices and tougher talks between carriers and providers. 

Redefining how healthcare is experienced.  Patients are using AI for clinical questions, and treatment options for in-home care are increasing. 

Take a hard look at your vendor partnerships. Regular audits help ensure each relationship delivers measurable value rather than quietly adding complexity. 

Focus on where the dollars actually go. High-cost claimants, specialty drugs, and conditions like cancer warrant dedicated strategies and clinical pathways. 

Treat pharmacy as a strategic priority. The pace of innovation requires close collaboration with your PBM and ongoing attention to the pipeline. 

Broaden your definition of wellbeing. Financial stability and mental health are inseparable from physical health, and your benefits should reflect that. 

Let your data guide the conversation. Integrated analytics across medical, pharmacy, and vendor performance create an informed strategy.